Melanoma, Familial - 25 Studies Found

Active, not recruiting : Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
: Cutaneous Malignant Melanoma
: 2012-12-05
:
  • Drug: Vitamin D

Completed : Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
: Cutaneous Malignant Melanoma
: 2011-11-26
: Procedure: Biopsy Biopsy Other Name: n.a.
Completed : Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
: N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
: 2012-09-14
:
  • Drug: Pimasertib Pimasertib wi
Completed : MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
: Cutaneous Melanoma by AJCC V7 Stage
: 2014-06-13
:
  • Procedure: Wide Local Excision = 1cm Margin

Not yet recruiting : Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma
:
  • Cutaneous Melanoma
  • Melanoma

: 2016-08-02
:
  • Procedure: Sentinel Lymph Node Biopsy

Active, not recruiting : Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes
: Cutaneous Melanoma
: 2014-12-18
Completed : Use of 852A in Metastatic Cutaneous Melanoma.
:
  • Melanoma
  • Unresectable Metatstatic Cutaneous Melanoma

: 2005-09-13
: Drug: 852A
Recruiting : Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma
:
  • Metastatic Melanoma
  • Recurrent Melanoma of the Skin
  • : 2015-10-20
    :
    • Drug: Ibrutinib Given PO
No longer available : Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
:
  • Metastatic Liver Cancer
  • Ocular Melanoma
  • Drug: Melphalan
  • Device: Percutaneous Hepat
Recruiting : Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients
: Cutaneous Melanoma
: 2012-11-14
:
  • Biological: CSF470 vaccine, BCG, Molgramostim
Next >>>